Laumas Sandeep
SEC insider (Form 3/4/5 filer). CIK 0001721664. Director at Unicycive Therapeutics, Inc. (UNCY) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in MOUNTAIN VIEW, CA.
Companies Laumas Sandeep has filed insider reports for
- Unicycive Therapeutics, Inc. (UNCY): Director
- BioXcel Therapeutics, Inc. (BTAI): Director
- Instil Bio, Inc. (TIL): Officer, CFO and CBO
Laumas Sandeep
CIK: 0001721664
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
47.9K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
42.1K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
84.2K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
84.2K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
42.1K shares- - Jan 9, 2026BTAI
BioXcel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
17K shares- - Sep 10, 2025TIL
Instil Bio, Inc.
SaleDirect17.5K shares at avg. $23.04$404K - Sep 10, 2025TIL
Instil Bio, Inc.
ExerciseDirect17K shares at avg. $11.60$197K - Sep 10, 2025TIL
Instil Bio, Inc.
SaleDirect12.5K shares at avg. $23.88$298K - Sep 10, 2025TIL
Instil Bio, Inc.
ExerciseDirect13K shares at avg. $12.68$165K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award Restricted Stock Units | 47,941 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award Restricted Stock Units | 42,100 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award Restricted Stock Units | 84,200 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award Restricted Stock Units | 84,200 | - | - | Direct |
| May 14, 2026 | UNCY Unicycive Therapeutics, Inc. | Award Restricted Stock Units | 42,100 | - | - | Direct |
| Jan 9, 2026 | BTAI BioXcel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 17,000 | - | - | Direct |
| Sep 10, 2025 | TIL Instil Bio, Inc. | Sale | 17,539 | $23.04 | $404,099 | Direct |
| Sep 10, 2025 | TIL Instil Bio, Inc. | Exercise | 17,000 | $11.60 | $197,200 | Direct |
| Sep 10, 2025 | TIL Instil Bio, Inc. | Sale | 12,461 | $23.88 | $297,569 | Direct |
| Sep 10, 2025 | TIL Instil Bio, Inc. | Exercise | 13,000 | $12.68 | $164,840 | Direct |
1-10 of 13 transactions